002589.SZ · 瑞康医药
China A-shares · RS rating 85 · As of 2026-10-14
| Price | 3.15 CNY |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 85 / 62 / 91 / 78 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 27 / 34 |
| Industry group (rank) | Medical-Hospitals (29) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.0% |
| Distance from 52-week high | +32.8% |
| Market cap (USD) | $753.9M |